The PROCAMIO Study – Procainamide or Amiodarone for Stable Wide QRS Tachycardia

Background 2017 AHA/ACC guidelines for the treatment of hemodynamically stable patients with ventricular tachycardia (VT) include the following recommendations:1 Intravenous procainamide can be useful to terminate VT. (Class IIa) Intravenous amiodarone or sotalol may be considered to terminate VT. (Class IIb) In 2013, deSouza et al conducted a systematic literature Read more…

Wednesday Wrap-up 11/28 – Anaphylaxis, AV Node Blocks and Cardiotoxic Drugs

For those who were not in conference yesterday: Dr. Rushabh Shah discussed AV nodal blocks: For all AV blocks consider: beta blocker or calcium channel blocker overdose, hyperkalemia, inferior MI, cardiomyopathy, and myocarditis 1st degree and 2nd degree Mobitz type 1 AV block: typically benign 2nd degree Mobitz type 2: Read more…

Administration Mini-Fellowship September Meeting: Physician Leadership

We are excited to announce the reinstatement of the Administration Mini-Fellowship with our meeting last month. The Administration Mini-Fellowship will be a learning and networking group advised by Dr. Ninfa Mehta, SUNY Downstate’s ED Medical Director. At our first meeting we discussed physician leadership & hospital performance from 2 articles: Read more…